RESPONSIfVE: efficacy and therapeutic response to Procoralan® in the treatment of chronic stable angina pectoris in routine medical practice a prospective non-interventional study

Trial Profile

RESPONSIfVE: efficacy and therapeutic response to Procoralan® in the treatment of chronic stable angina pectoris in routine medical practice a prospective non-interventional study

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2016

At a glance

  • Drugs Ivabradine (Primary) ; Beta-adrenergic receptor antagonists
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Acronyms RESPONSIfVE
  • Sponsors Servier
  • Most Recent Events

    • 18 Jul 2016 Results published in the Advances in Therapy
    • 30 Sep 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
    • 19 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top